Ekso Bionics Holdings (LTS:0IFR) Debt-to-Equity : 0.49 (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Ekso Bionics Holdings Debt-to-Equity?

Ekso Bionics Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $1.62 Mil. Ekso Bionics Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $5.22 Mil. Ekso Bionics Holdings's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $14.05 Mil. Ekso Bionics Holdings's debt to equity for the quarter that ended in Mar. 2024 was 0.49.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Ekso Bionics Holdings's Debt-to-Equity or its related term are showing as below:

LTS:0IFR' s Debt-to-Equity Range Over the Past 10 Years
Min: -137.64 Med: 0.26 Max: 4.23
Current: 0.49

During the past 12 years, the highest Debt-to-Equity Ratio of Ekso Bionics Holdings was 4.23. The lowest was -137.64. And the median was 0.26.

LTS:0IFR's Debt-to-Equity is ranked worse than
71.1% of 699 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs LTS:0IFR: 0.49

Ekso Bionics Holdings Debt-to-Equity Historical Data

The historical data trend for Ekso Bionics Holdings's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ekso Bionics Holdings Debt-to-Equity Chart

Ekso Bionics Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.57

0.87

0.06

0.30

0.57

Ekso Bionics Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															0.35	0.42	0.49	0.57	0.49

Competitive Comparison of Ekso Bionics Holdings's Debt-to-Equity

For the Medical Instruments & Supplies subindustry, Ekso Bionics Holdings's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ekso Bionics Holdings's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ekso Bionics Holdings's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Ekso Bionics Holdings's Debt-to-Equity falls into.

Ekso Bionics Holdings Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Ekso Bionics Holdings's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.613	+	5.555)	/	12.606
	=	0.57

Ekso Bionics Holdings's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.622	+	5.22)	/	14.051
	=	0.49

Ekso Bionics Holdings (LTS:0IFR) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Ekso Bionics Holdings Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Ekso Bionics Holdings's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Ekso Bionics Holdings (LTS:0IFR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ekso Bionics Holdings Inc (LTS:0IFR) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

EKSO:USA 23E2:Germany

Address

101 Glacier Point, Suite A, San Rafael, CA, USA, 94901

Website

https://www.eksobionics.com

Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are EksoHealth and EksoWorks. All of the company's operations are held in the United States. The EksoHealth segment which derives majority revenue designs, engineers, manufactures and sells exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The regions company operates in are the Americas, EMEA, and APAC.

Ekso Bionics Holdings (LTS:0IFR) Headlines

No Headlines